Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2021 1
2022 1
2023 1
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3 results

Results by year

Filters applied: . Clear all
Page 1
Novel Supreme Drug-Eluting Stents With Early Synchronized Antiproliferative Drug Delivery to Inhibit Smooth Muscle Cell Proliferation After Drug-Eluting Stents Implantation in Coronary Artery Disease: Results of the PIONEER III Randomized Clinical Trial.
Lansky AJ, Kereiakes DJ, Baumbach A, Windecker S, Hussain Y, Pietras C, Dressler O, Issever O, Curtis M, Bertolet B, Zidar JP, Smits PC, Alfonso Jiménez Díaz V, McLaurin B, Hofma S, Cequier Á, Dib N, Benit E, Mathur A, Brogno D, Berland J, Wykrzykowska J, Piegari G, Brugaletta S, Saito S, Leon MB; PIONEER III Trial Investigators. Lansky AJ, et al. Circulation. 2021 Jun;143(22):2143-2154. doi: 10.1161/CIRCULATIONAHA.120.052482. Epub 2021 Apr 6. Circulation. 2021. PMID: 33820424 Clinical Trial.
The Supreme Biodegradable Polymer DES in Acute and Chronic Coronary Syndromes: A PIONEER III Substudy.
Hussain Y, Saito S, Curtis M, Kereiakes DJ, Baumbach A, Zidar JP, McLaurin B, Dib N, Smits PC, Jiménez Díaz VA, Cequier Á, Hofma SH, Pietras C, Dressler O, Issever MO, Windecker S, Leon MB, Lansky AJ; PIONEER III Trial Investigators. Hussain Y, et al. J Soc Cardiovasc Angiogr Interv. 2023 Mar 27;2(3):100629. doi: 10.1016/j.jscai.2023.100629. eCollection 2023 May-Jun. J Soc Cardiovasc Angiogr Interv. 2023. PMID: 39130696 Free PMC article.
Outcomes of the Novel Supreme Drug-Eluting Stent in Complex Coronary Lesions: A PIONEER III Substudy.
Patel KP, Lansky AJ, Kereiakes DJ, Windecker S, Cristea E, Pietras C, Dressler O, Issever MO, Curtis M, Bertolet B, Zidar JP, Smits PC, Jiménez Díaz VA, McLaurin B, Brogno DA, Janssens L, Vrolix MC, Gómez-Blázquez I, Sahul ZH, Kabour A, Salido L, Cleman M, Saito S, Leon MB, Baumbach A; PIONEER III Trial Investigators. Patel KP, et al. J Soc Cardiovasc Angiogr Interv. 2022 Jan 30;1(1):100004. doi: 10.1016/j.jscai.2021.100004. eCollection 2022 Jan-Feb. J Soc Cardiovasc Angiogr Interv. 2022. PMID: 39130138 Free PMC article.